• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Lunar results show moderate growth

Article

Bone densitometry firm Lunar of Madison, WI, released financial results for its fourth quarter (end-June) that showed a respectable 9% increase in revenue. The company appears to have enjoyed a slightly better quarter than competitor Hologic, which saw

Bone densitometry firm Lunar of Madison, WI, released financial results for its fourth quarter (end-June) that showed a respectable 9% increase in revenue. The company appears to have enjoyed a slightly better quarter than competitor Hologic, which saw its revenues climb only 3%.

For the quarter, Lunar had revenues of $22.2 million, compared with $20.3 million in the fourth quarter of 1996. The company enjoyed net income of $3.6 million, compared with a profit of $3.1 million in the same period of 1996. For the year, Lunar had sales of $81.5 million, up 22% compared with $66.9 million in 1996. The company finished fiscal 1997 with a net profit of $14.3 million, compared with net income of $9.2 million the year before.

Lunar president Dr. Richard Mazess reported that the company is enjoying continued strong demand for its DPIX-IQ x-ray densitometer, particularly in the U.S. The company said that sales of its Artoscan MRI systems and Orca mini-C-arms increased as well, with revenues from both these product lines climbing 42% to $9.1 million for the year.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.